leadf
logo-loader
NASDAQ:ADXS

Advaxis

Receive alerts
Market:
NASDAQ
Market Cap:
$28.54 m
Price
0.43 USD
Change
-3.15%
52 weeks high
1.47
52 weeks low
0.21

In brief

Advaxis is a development-stage biotechnology company with the focus on developing cancer vaccines that utilize multiple mechanisms of immunity.